Medtronic plc (MDT) operating KPIs
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — Worldwide Revenue ($M) ($M)
Effective Q1 FY2027, Medtronic reorganized Cardiovascular from 3 divisions (CRHF, SHA, CPV) into 4 divisions (EP Therapies, IC Therapies, CV Surgery, PV Health) without publishing Q2–Q4 FY2026 restated quarters yet; legacy 3 divisions are retained through FY2026Q4 per Step 5, while new divisions (<3 consecutive quarters) are in excluded.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up cardiac rhythm & heart failure (crhf — legacy through fy2026q4) — worldwide revenue ($m)
- Cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — Organic Revenue Growth YoY (%)18.2% · Q4 FY26
- Cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — Foreign Currency Impact ($M)62 · Q4 FY26
- Cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — Reported Revenue Growth YoY (%)21.8% · Q4 FY26
- Cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — U.S. Revenue ($M)1,105 · Q4 FY26
- Cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — International Revenue ($M)1,005 · Q4 FY26
Cite this data
StockData. (2026). Medtronic Cardiac Rhythm & Heart Failure (CRHF — Legacy through FY2026Q4) — Worldwide Revenue ($M) ($M), quarterly Q3 FY15–Q4 FY26 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/cv-crhf-leg-ww-rev
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.